Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance

Respiratory Medicine

Volumn 109, Issue 6, 2015, Pages 716-726

  McDonnell, Melissa J ^a   Jary, Hannah R ^a   Perry, Audrey ^a   Macfarlane, James G ^a   Hester, Katy L M ^a   Small, Therese ^a   Molyneux, Catherine ^a   Perry, John D ^a   Walton, Katherine E ^a   De Soyza, Anthony ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Bronchiectasis; Exacerbation; Longitudinal; Microbiology; Pseudomonas aeruginosa

Indexed keywords

ADULT; ARTICLE; BRONCHIECTASIS; COHORT ANALYSIS; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON CYSTIC FIBROSIS BRONCHIECTASIS; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPUTUM CULTURE; AGED; ANTIBIOTIC RESISTANCE; DISEASE COURSE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PSEUDOMONAS INFECTIONS; SPUTUM;

ANTIINFECTIVE AGENT;

AGED; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; COHORT STUDIES; DISEASE PROGRESSION; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HAEMOPHILUS INFLUENZAE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM;

EID: 84931570325     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.07.021     Document Type: Article

References (36)

1. A.E. Seitz, K.N. Olivier, J. Adjemian, S.M. Holland, and D.R. Prevots Trends in bronchiectasis among medicare beneficiaries in the United States, 2000-2007 Chest 2012
2. A.E. Seitz, K.N. Olivier, C.A. Steiner, R. Montes de Oca, S.M. Holland, and D.R. Prevots Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006 Chest 138 4 2010 Oct 944 949
3. F.C. Ringshausen, A. de Roux, M.W. Pletz, N. Hämäläinen, T. Welte, and J. Rademacher Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends PLoS One 8 8 2013 Aug 1 e71109 10.1371/journal.pone.0071109
4. M.R. Loebinger, A.U. Wells, D.M. Hansell, N. Chinyanganya, A. Devaraj, and M. Meister Mortality in bronchiectasis: a long-term study assessing the factors influencing survival Eur Respir J 34 4 2009 843 849
5. M.C. Pasteur, D. Bilton, and A.T. Hill British Thoracic Society guideline for non-CF bronchiectasis Thorax 65 Suppl. 1 2010 i1 58
6. M.C. Pasteur, S.M. Helliwell, S.J. Houghton, S.C. Webb, J.E. Foweraker, and R.A. Coulden An investigation into causative factors in patients with bronchiectasis Am J Respir Critical Care Med 162 4 Pt 1 2000 1277 1284
7. C.B. Wilson, P.W. Jones, C.J. O'Leary, D.M. Hansell, P.J. Cole, and R. Wilson Effect of sputum bacteriology on the quality of life of patients with bronchiectasis Eur Respir J 10 8 1997 1754 1760
8. G. Davies, A.U. Wells, S. Doffman, S. Watanabe, and R. Wilson The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Eur Respir J 28 5 2006 974 979
9. J. Eller, A. Ede, T. Schaberg, M.S. Niederman, H. Mauch, and H. Lode Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function Chest 113 1998 1542 1548
10. G.A. Anwar, M.J. McDonnell, S.A. Worthy, S.C. Bourke, G. Afolabi, J. Lordan, P.A. Corris, A. Desoyza, P. Middleton, C. Ward, and R.M. Rutherford Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study Respir Med 107 7 2013 1001 1007
11. Anonymous British Society for Antimicrobial Chemotherapy BSAC methods for antimicrobial susceptibility testing, version 9 2010 British Society for Antimicrobial Chemotherapy http://www.bsac.org.uk/Susceptibility+Testing/GUIDELINES+Standardized+Disc+Susceptibility+Testing+Method
12. Anonymous European Committee on Antimicrobial Susceptibility Testing Antimicrobial susceptibility testing; EUCAST disk diffusion method 2012 European Committee on Antimicrobial Susceptibility Testing http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk-test-documents/Manual-v-2.1-EUCAST-Disk-Test.pdf
13. M.E. Falagas, P.K. Koletsi, and I.A. Bliziotis The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa J Med Microbiol 55 Pt 12 2006 1619 1629
14. V. Brusasco, R. Crapo, and G. Viegi Coming together: the ATS/ERS consensus on clinical pulmonary function testing Eur Respir J 26 1 2005 1 2
15. M.R. Miller, R. Crapo, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, P. Enright, CPMvd Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi, and J. Wanger General considerations for lung function testing Eur Respir J 26 1 2005 153 161
16. J.D. Chalmers, P. Goeminne, S. Aliberti, M.J. McDonnell, S. Lonni, J. Davidson, L. Poppelwell, W. Salih, A. Pesci, L.J. Dupont, T.C. Fardon, A. De Soyza, and A.T. Hill The bronchiectasis severity index. An international derivation and validation study Am J Respir Critical Care Med 189 5 2014 576 585
17. M. Malta, L.O. Cardoso, F.I. Bastos, M.M. Magnanini, and C.M. Silva STROBE initiative: guidelines on reporting observational studies Rev saude Publica 44 3 2010 559 565
18. D. Weycker, J. Edelsberg, G. Oster, and G. Tino Prevalence and economic burden of bronchiectasis Clin Pulm Med 12 2005 205
19. M.A. Martinez-Garcia, J.J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis Chest 132 5 2007 1565 1572
20. P.T. King, S.R. Holdsworth, N.J. Freezer, E. Villanueva, and P.W. Holmes Microbiologic follow-up study in adult bronchiectasis Respir Med 101 8 2007 1633 1638
21. P.L. Ho, K.N. Chan, M.S. Ip, W.K. Lam, C.S. Ho, and K.Y. Yuen The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis Chest 114 6 1998 1594 1598
22. J.H. Lee, Y.K. Kim, H.J. Kwag, and J.H. Chang Relationships between high-resolution computed tomography, lung function and bacteriology in stable bronchiectasis J Korean Med Sci 19 1 2004 62 68
23. K. Cheng, R.L. Smyth, J.R. Govan, C. Doherty, C. Winstanley, and N. Denning Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic Lancet 348 9028 1996 639 642
24. J.L. Fothergill, M.J. Walshaw, and C. Winstanley Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections Eur Respir J 40 1 2012 227 238
25. A. De Soyza, J.S. Brown, and M.R. Loebinger Bronchiectasis research academic network. Research priorities in bronchiectasis Thorax 68 2013 695 696
26. J.E. Foweraker, C.R. Laughton, D.F. Brown, and D. Bilton Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing J Antimicrob Chemother 55 6 2005 921 927
27. M.I. Gillham, S. Sundaram, C.R. Laughton, C.S. Haworth, D. Bilton, and J.E. Foweraker Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis J Antimicrob Chemother 63 4 2009 728 732
28. D. Hadjiliadis, M.P. Steele, C. Chaparro, L.G. Singer, T.K. Waddell, and M.A. Hutcheon Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria J Heart Lung Transpl 26 8 2007 834 838
29. S.A. Evans, S.M. Turner, B.J. Bosch, C.C. Hardy, and M.A. Woodhead Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa Eur Respir J 9 8 1996 1601 1604
30. A.T. Hill, M. Pasteur, C. Cornford, S. Welham, and D. Bilton Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis Prim Care Respir J 20 2 2010 135 140
31. Dhar R, Anwar GA, Bourke SC, Doherty L, Middleton P, Ward C, et al. Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa. Thorax. 65(6):553.
32. Metersky ML. New treatment options for bronchiectasis. Ther Adv Respir Dis. 4(2):93-99.
33. M.P. Murray, K. Turnbull, S. Macquarrie, and A.T. Hill Assessing response to treatment of exacerbations of bronchiectasis in adults Eur Respir J 33 2 2009 312 318
34. M.P. Murray, J.R. Govan, C.J. Doherty, A.J. Simpson, T.S. Wilkinson, and J.D. Chalmers A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis Am J Respir Crit Care Med 183 4 2010 491 499
35. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, and J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 10 2002 847 852
36. T.A. Seemungal, G.C. Donaldson, E.A. Paul, J.C. Bestall, D.J. Jeffries, and J.A. Wedzicha Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 5 Pt 1 1998 1418 1422